Literature DB >> 18193216

Application of stem cells in bone repair.

Elaine Y L Waese1, Rita A Kandel, Rita R Kandel, William L Stanford.   

Abstract

Bone has the ability to repair minor injuries through remodeling. However, when the host source of osteoprogenitors is compromised at the defect site, one effective treatment may be cell-based therapy, as it replenishes the area of bone loss with cells possessing osteogenic potential. This review is a concise comparison of different types of stem cells that have the potential to be used in tissue-engineered scaffolds for bone repair. The clinical use of mesenchymal stem or stromal cells isolated from the bone marrow for treating various diseases has been well documented. However, the scarcity of these cells prompts the search for alternative sources of multipotential cells such as amniotic fluid stem cells and umbilical cord perivascular cells. Embryonic stem cells are another controversial source of cells with osteogenic potential. These cells have the ability to differentiate into all cell types of the adult body. Issues such as the use of human embryos and the risk of contamination from animal-derived culture components continue to prevent the therapeutic use of ESCs. As a result, abundant research has been carried out to design defined culture conditions for culturing ESCs, and alternative strategies such as the generation of induced pluripotent stem cells are being developed to eliminate the need for using embryos for cell derivation. In addition to the cell source, the ability to control stem cell differentiation into functional bone and the choice of biomaterial are also paramount objectives that are being examined in research and clinical trials.

Entities:  

Mesh:

Year:  2008        PMID: 18193216     DOI: 10.1007/s00256-007-0438-8

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  73 in total

1.  Spine fusion using cell matrix composites enriched in bone marrow-derived cells.

Authors:  George F Muschler; Hironori Nitto; Yoichi Matsukura; Cynthia Boehm; Antonio Valdevit; Helen Kambic; William Davros; Kimerly Powell; Kirk Easley
Journal:  Clin Orthop Relat Res       Date:  2003-02       Impact factor: 4.176

Review 2.  Mesenchymal stem cell aging.

Authors:  Christine Fehrer; Günter Lepperdinger
Journal:  Exp Gerontol       Date:  2005-08-25       Impact factor: 4.032

3.  Mesenchymal stem cells from osteoporotic patients produce a type I collagen-deficient extracellular matrix favoring adipogenic differentiation.

Authors:  J P Rodríguez; L Montecinos; S Ríos; P Reyes; J Martínez
Journal:  J Cell Biochem       Date:  2000-09-14       Impact factor: 4.429

4.  Human embryonic stem cells express an immunogenic nonhuman sialic acid.

Authors:  Maria J Martin; Alysson Muotri; Fred Gage; Ajit Varki
Journal:  Nat Med       Date:  2005-01-30       Impact factor: 53.440

5.  Effect of regional gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.

Authors:  Jeffrey C Wang; Linda E A Kanim; Stephen Yoo; Patricia A Campbell; Arnold J Berk; Jay R Lieberman
Journal:  J Bone Joint Surg Am       Date:  2003-05       Impact factor: 5.284

Review 6.  Osteochondral defects: present situation and tissue engineering approaches.

Authors:  J F Mano; R L Reis
Journal:  J Tissue Eng Regen Med       Date:  2007 Jul-Aug       Impact factor: 3.963

7.  Patients with primary osteoarthritis show no change with ageing in the number of osteogenic precursors.

Authors:  R O Oreffo; A Bennett; A J Carr; J T Triffitt
Journal:  Scand J Rheumatol       Date:  1998       Impact factor: 3.641

8.  Bone formation following OP-1 implantation is improved by addition of autogenous bone marrow cells in a canine femur defect model.

Authors:  Hidetake Takigami; Ken Kumagai; Larry Latson; Daisuke Togawa; Thomas Bauer; Kimerly Powell; Robert S Butler; George F Muschler
Journal:  J Orthop Res       Date:  2007-10       Impact factor: 3.494

9.  Osterix enhances proliferation and osteogenic potential of bone marrow stromal cells.

Authors:  Qisheng Tu; Paloma Valverde; Jake Chen
Journal:  Biochem Biophys Res Commun       Date:  2006-01-30       Impact factor: 3.575

10.  Aging of mesenchymal stem cell in vitro.

Authors:  Mandana Mohyeddin Bonab; Kamran Alimoghaddam; Fatemeh Talebian; Syed Hamid Ghaffari; Ardeshir Ghavamzadeh; Behrouz Nikbin
Journal:  BMC Cell Biol       Date:  2006-03-10       Impact factor: 4.241

View more
  13 in total

1.  In vitro and in vivo study of human amniotic fluid-derived stem cell differentiation into myogenic lineage.

Authors:  Jean Gekas; Guillaume Walther; Daniel Skuk; Emmanuel Bujold; Isabelle Harvey; Olivier François Bertrand
Journal:  Clin Exp Med       Date:  2010-03       Impact factor: 3.984

Review 2.  Osteogenic differentiation of amniotic fluid mesenchymal stromal cells and their bone regeneration potential.

Authors:  Caterina Pipino; Assunta Pandolfi
Journal:  World J Stem Cells       Date:  2015-05-26       Impact factor: 5.326

3.  Human stem cell delivery for treatment of large segmental bone defects.

Authors:  Kenneth M Dupont; Kapil Sharma; Hazel Y Stevens; Joel D Boerckel; Andrés J García; Robert E Guldberg
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-19       Impact factor: 11.205

Review 4.  Stem cell paracrine actions and tissue regeneration.

Authors:  Priya R Baraniak; Todd C McDevitt
Journal:  Regen Med       Date:  2010-01       Impact factor: 3.806

5.  Characterization and comparison of osteoblasts derived from mouse embryonic stem cells and induced pluripotent stem cells.

Authors:  Ming-San Ma; Vishnu Kannan; Anneriek E de Vries; Marcin Czepiel; Evelyn M Wesseling; Veerakumar Balasubramaniyan; Roel Kuijer; Arjan Vissink; Sjef C V M Copray; Gerry M Raghoebar
Journal:  J Bone Miner Metab       Date:  2016-01-08       Impact factor: 2.626

Review 6.  Stem Cells and Tissue Engineering: Regeneration of the Skin and Its Contents.

Authors:  Amy L Strong; Michael W Neumeister; Benjamin Levi
Journal:  Clin Plast Surg       Date:  2017-04-22       Impact factor: 2.017

7.  BMP-non-responsive Sca1+ CD73+ CD44+ mouse bone marrow derived osteoprogenitor cells respond to combination of VEGF and BMP-6 to display enhanced osteoblastic differentiation and ectopic bone formation.

Authors:  Vedavathi Madhu; Ching-Ju Li; Abhijit S Dighe; Gary Balian; Quanjun Cui
Journal:  PLoS One       Date:  2014-07-21       Impact factor: 3.240

8.  Use of stem-cell sheets expressing bone morphogenetic protein-7 in the management of a nonunion radial fracture in a Toy Poodle.

Authors:  Jaeyong Song; Yongsun Kim; Oh-Kyeong Kweon; Byung-Jae Kang
Journal:  J Vet Sci       Date:  2017-12-31       Impact factor: 1.672

9.  Regulation of Osteogenic Differentiation of Placental-Derived Mesenchymal Stem Cells by Insulin-Like Growth Factors and Low Oxygen Tension.

Authors:  Amer Youssef; Victor K M Han
Journal:  Stem Cells Int       Date:  2017-09-12       Impact factor: 5.443

10.  Lim mineralization protein 3 induces the osteogenic differentiation of human amniotic fluid stromal cells through Kruppel-like factor-4 downregulation and further bone-specific gene expression.

Authors:  Marta Barba; Filomena Pirozzi; Nathalie Saulnier; Tiziana Vitali; Maria Teresa Natale; Giandomenico Logroscino; Paul D Robbins; Andrea Gambotto; Giovanni Neri; Fabrizio Michetti; Enrico Pola; Wanda Lattanzi
Journal:  J Biomed Biotechnol       Date:  2012-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.